AnalystsInsight

Stephen Scouten (Piper Sandler): Analyst Track Record and Price‑Target Accuracy

How often Stephen Scouten’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 902 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

Key takeaways

  • Stephen Scouten ranks #469 of 1,000 analysts in Exent’s scoring (4.8★).
  • 53.4% of price targets were reached over 7 years, versus 52.4% for the average analyst.
  • Median time to reach a target: 98 days; 70.4% of calls were up 12 months later.
  • Most‑covered stocks: PNFP, AMTB, SSB, SBCF.
  • Free on Exent: Stephen Scouten’s full record, with ratings 3 days after publication.

Stephen Scouten’s track record at a glance

Stephen Scouten of Piper Sandler ranks #469 of the 1,000 analysts Exent scores, with a 4.8★ rating and a focus on financials. Over a 7‑year lookback, 53.4% of Stephen’s price targets were reached, 1.0 points above the 52.4% average across all analysts.

MetricStephen ScoutenAll analysts
Price‑target hit rate53.4%52.4%
Median days to hit target98 days91 days
Calls up after 12 months70.4%64.0%
Median 12‑month return of calls+15.0%+13.4%
Hit rate, last 2 years53.8%—
Average worst drop after a call−13.1%—
Ratings in the sample902—
Stocks covered37—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetStephen Scouten
Under 30 days19.0%
30–90 days27.0%
90–180 days27.9%
Over 180 days26.1%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Stephen Scouten covers most

StockRatings in the sample
PNFP23
AMTB22
SSB21
SBCF20
TRMK19
AUB19
FBNC18
USCB18

In the past year Stephen’s ratings were 58% Buy, 42% Hold and 0% Sell.

Stephen Scouten’s latest ratings

DateStockActionRatingPrice target
Sep 9, 2026UCBReiterated: HoldHold$38.00
Sep 4, 2026SFNCUpgraded: BuyBuy$27.50
Aug 27, 2026FFINInitiated Coverage: HoldHold$35.00
Aug 27, 2026TCBXInitiated Coverage: BuyBuy$53.00
Aug 26, 2026RNSTReiterated: BuyBuy$48.00
Jul 30, 2026TRMKReiterated: HoldHold$47.00
Jul 30, 2026RNSTReiterated: BuyBuy$48.00
Jul 30, 2026PBReiterated: HoldHold$80.00
Jul 30, 2026SBCFReiterated: HoldHold$35.50
Jul 29, 2026FBNCReiterated: HoldHold$65.00
Jul 28, 2026HTHReiterated: HoldHold$42.00
Jul 27, 2026ABCBReiterated: HoldHold$92.00
  • Sep 9, 2026
    Stock
    UCB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $38.00
  • Sep 4, 2026
    Stock
    SFNC
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $27.50
  • Aug 27, 2026
    Stock
    FFIN
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $35.00
  • Aug 27, 2026
    Stock
    TCBX
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $53.00
  • Aug 26, 2026
    Stock
    RNST
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $48.00
  • Jul 30, 2026
    Stock
    TRMK
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $47.00
  • Jul 30, 2026
    Stock
    RNST
    Action
    Reiterated: Buy
    Rating
    Buy
    Price target
    $48.00
  • Jul 30, 2026
    Stock
    PB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $80.00
  • Jul 30, 2026
    Stock
    SBCF
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $35.50
  • Jul 29, 2026
    Stock
    FBNC
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $65.00
  • Jul 28, 2026
    Stock
    HTH
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $42.00
  • Jul 27, 2026
    Stock
    ABCB
    Action
    Reiterated: Hold
    Rating
    Hold
    Price target
    $92.00

Stephen’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows Stephen Scouten’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Stephen Scouten ranks #469 of 1,000 with a 4.8★ rating. 53.4% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 70.4% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Stephen Scouten’s success rate is 65.2% by the ranking source and 53.4% by Exent’s price-target hit-rate backtest, with a median of 98 days to reach a target.

Stephen Scouten (Piper Sandler) covers 37 stocks, mostly in financials. The most frequently rated are PNFP, AMTB, SSB, SBCF, TRMK.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.